Ketotifen in adult asthma.

Abstract

The efficacy and adverse effects of ketotifen 1 mg twice daily and 2 mg twice daily were compared with placebo in 50 patients with atopic asthma in a multicentre, double-blind study. Ketotifen in the higher dosage caused a slight reduction in salbutamol usage and a modest improvement in breathing in patients not already receiving inhaled corticosteroids. The drug was ineffective in patients receiving inhaled corticosteroids. Drowsiness was a troublesome effect causing withdrawal from treatment or reduction of dosage in seven patients while receiving ketotifen compared with only three while receiving placebo.

Statistics

0100200300'85'88'91'94'97'00'03'06'09'12'15
Citations per Year

289 Citations

Semantic Scholar estimates that this publication has 289 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Dyson1980KetotifenIA, title={Ketotifen in adult asthma.}, author={Anthony J. Dyson and Amy D MacKay}, journal={British medical journal}, year={1980}, volume={280 6217}, pages={862} }